| Name | Title | Contact Details |
|---|---|---|
Shakima Wells |
Associate General Counsel | Profile |
Advanced Cardiac Therapeutics, Inc. is a pre-commercial, medical device company that designs and manufactures a catheter-based system for the treatment of patients with AFIB. AFIB is characterized by an irregular, often rapid heart rate that commonly causes poor systemic blood flow. The Company`s mission is to dramatically improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system. ACT`s technology is the only system in the world to leverage feedback from four unique capabilities: temperature sensing, low irrigation flow rates, high resolution EGM attenuation and contact sensing. The ACT system is not currently approved for commercial use.
Founded in 1998, REVA Medical is dedicated to developing minimally invasive medical devices that leverage its proprietary biomaterial and stent technologies to improve the treatment of coronary artery disease. Guided by an executive management team and scientific advisors with extensive product development and clinical interventional cardiology experience, REVA’s initial focus is the development of a drug-eluting bioresorbable coronary scaffold to advance the treatment of cardiovascular disease, the leading cause of death worldwide.
Restructured under new ownership in 2015, TranS1 has emerged stronger than ever – ready to support a product line that provides a foundation for living well, driven by surgeon innovation. Our impressive team includes experienced R&D, Sales and Professional Education professionals. The TranS1 team is focused on resilient and continuous training of its sales force and physician customers, employing best in class training methods that ultimately benefit patients.
Sonomed is a New Hyde Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tri-Medical is a Lake Oswego, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.